These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9103548)

  • 1. Antisense targeting of delta opioid receptors in NG 108-15 cells: direct correlation between oligodeoxynucleotide uptake and receptor density.
    Lai J; Crook TJ; Payne A; Lynch RM; Porreca F
    J Pharmacol Exp Ther; 1997 Apr; 281(1):589-96. PubMed ID: 9103548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
    Bilsky EJ; Bernstein RN; Hruby VJ; Rothman RB; Lai J; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunofluorescence analysis of antisense oligodeoxynucleotide-mediated 'knock-down' of the mouse delta opioid receptor in vitro and in vivo.
    Lai J; Riedl M; Stone LS; Arvidsson U; Bilsky EJ; Wilcox GL; Elde R; Porreca F
    Neurosci Lett; 1996 Aug; 213(3):205-8. PubMed ID: 8873150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense oligodeoxynucleotides to the cloned delta receptor DOR-1: uptake, stability, and regulation of gene expression.
    Standifer KM; Jenab S; Su W; Chien CC; Pan YX; Inturrisi CE; Pasternak GW
    J Neurochem; 1995 Nov; 65(5):1981-7. PubMed ID: 7595481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of supraspinal antisense oligodeoxynucleotide treatment on delta-opioid receptor mRNA levels in mice.
    Lee CE; Kest B; Jenab S; Inturrisi CE
    Brain Res Mol Brain Res; 1997 Aug; 48(1):17-22. PubMed ID: 9379841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of delta opioid receptor and N-methyl-D-aspartate receptor-like immunoreactivity in retinoic acid-differentiated neuroblastoma x glioma (NG108-15) cells.
    Beczkowska IW; Gracy KN; Pickel VM; Inturrisi CE
    J Neurosci Res; 1997 Jan; 47(1):83-9. PubMed ID: 8981241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of morphine supersensitivity by an antisense oligodeoxynucleotide targeting the delta opioid receptor (DOR-1).
    Kest B; Lee CE; Mogil JS; Inturrisi CE
    Life Sci; 1997; 60(9):PL155-9. PubMed ID: 9048971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of EGFR antisense oligodeoxynucleotide on human hepatoma cell line.
    Gong ZB; Liu JM; Li YM
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):433-6. PubMed ID: 16109531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
    J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor growth inhibition in vivo and G2/M cell cycle arrest induced by antisense oligodeoxynucleotide targeting thymidylate synthase.
    Berg RW; Werner M; Ferguson PJ; Postenka C; Vincent M; Koropatnick DJ; Behrend E
    J Pharmacol Exp Ther; 2001 Aug; 298(2):477-84. PubMed ID: 11454908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor.
    Xu H; Wang X; Wang J; Rothman RB
    Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat.
    Fraser GL; Pradhan AA; Clarke PB; Wahlestedt C
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1135-41. PubMed ID: 11082450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model.
    Gleave M; Tolcher A; Miyake H; Nelson C; Brown B; Beraldi E; Goldie J
    Clin Cancer Res; 1999 Oct; 5(10):2891-8. PubMed ID: 10537358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mu-opioid receptor down-regulates differently from the delta-opioid receptor: requirement of a high affinity receptor/G protein complex formation.
    Chakrabarti S; Yang W; Law PY; Loh HH
    Mol Pharmacol; 1997 Jul; 52(1):105-13. PubMed ID: 9224819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice.
    Kest B; Lee CE; McLemore GL; Inturrisi CE
    Brain Res Bull; 1996; 39(3):185-8. PubMed ID: 8866695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo.
    Miyake H; Chi KN; Gleave ME
    Clin Cancer Res; 2000 May; 6(5):1655-63. PubMed ID: 10815883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of delta opioid receptor immunoreactivity in interneurons and pyramidal cells in the rat hippocampus.
    Commons KG; Milner TA
    J Comp Neurol; 1997 May; 381(3):373-87. PubMed ID: 9133574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of inhibition of hypertension by antisense oligonucleotides targeted to AT1 angiotensin receptor mRNA in spontaneously hypertensive rats.
    Gyurko R; Tran D; Phillips MI
    Am J Hypertens; 1997 May; 10(5 Pt 2):56S-62S. PubMed ID: 9160782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense studies of brain GABAA receptors.
    Karle J
    Dan Med Bull; 2002 May; 49(2):130-44. PubMed ID: 12064090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mu and delta opioid receptor immunoreactivity and mu receptor regulation in brainstem cells cultured from late fetal and early postnatal rats.
    Kivell BM; Day DJ; McDonald FJ; Miller JH
    Brain Res Dev Brain Res; 2004 Mar; 149(1):9-19. PubMed ID: 15013624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.